comparemela.com

Latest Breaking News On - Cullinan oncology - Page 15 : comparemela.com

Phase 1 Trial Will Test CLN-978 in B-Cell NHL

A phase 1 clinical trial just launched and will test the novel agent, CLN-978, for relapsed/refractory B-cell non-Hodgkin lymphoma.

Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2023 Financial Results

Phase 3 first-line study of zipalertinib in EGFR exon 20 insertion mutation non-small-cell lung cancer patients open to enrollment Initial monotherapy clinical data for CLN-619 presented at. -Today at 07:02 am- MarketScreener

Cullinan Oncology Announces First Patient Dosed In Phase 1 Trial Evaluating Cln-978, A Novel Cd19xcd3 T Cell Engager, In Relapsed/Refractory B-Cell No

Cullinan Oncology Announces First Patient Dosed In Phase 1 Trial Evaluating Cln-978, A Novel Cd19xcd3 T Cell Engager, In Relapsed/Refractory B-Cell No
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Cullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-978, a Novel CD19xCD3 T cell Engager, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Cullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-978, a Novel CD19xCD3 T cell Engager, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Cullinan Oncology Stock (NASDAQ:CGEM), Quotes and News Summary

Cullinan Oncology Stock (NASDAQ:CGEM), Quotes and News Summary
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.